van Staa, T. P., Leufkens, H. G., Abenhaim, L. ., Begaud, B. ., Zhang, B. ., & Cooper, C. . (2000). Use of oral corticosteroids in the United Kingdom. Qjm.
C. Cooper
First name
C.
Last name
Cooper
van Staa, T. P., Wegman, S. ., de Vries, F. ., Leufkens, B. ., & Cooper, C. . (2001). Use of statins and risk of fractures. Jama.
van Staa, T. P., Dennison, E. M., Leufkens, H. G., & Cooper, C. . (2001). Epidemiology of fractures in England and Wales. Bone.
van Staa, T. P., Abenhaim, L. ., Cooper, C. ., Zhang, B. ., & Leufkens, H. G. (2001). Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol.
van Staa, T. P., Leufkens, H. G., & Cooper, C. . (2001). Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. http://doi.org/10.1359/jbmr.2001.16.3.581
van Staa, T. P., Leufkens, H. G., & Cooper, C. . (2002). Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporos Int. http://doi.org/10.1007/s001980200084
van Staa, T. P., Selby, P. ., Leufkens, H. G., Lyles, K. ., Sprafka, J. M., & Cooper, C. . (2002). Incidence and natural history of Paget\textquoterights disease of bone in England and Wales. J Bone Miner Res. http://doi.org/10.1359/jbmr.2002.17.3.465
van Staa, T. P., Leufkens, H. G., & Cooper, C. . (2002). Utility of medical and drug history in fracture risk prediction among men and women. Bone.
van Staa, T. P., Boulton, F. ., Cooper, C. ., Hagenbeek, A. ., Inskip, H. ., & Leufkens, H. G. (2003). Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol. http://doi.org/10.1002/ajh.10295
Souverein, P. C., van Staa, T. P., Egberts, A. C., De la Rosette, J. J., Cooper, C. ., & Leufkens, H. G. (2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med.